Per the deal terms, Sarepta will acquire exclusive rights to Arrowhead’s seven pipeline ... especially the recently approved DMD gene therapy Elevidys. Year to date, Sarepta Therapeutics ...

Arrowhead Pharmaceuticals' stock rallied 17% due to significant pipeline developments and strategic partnerships. Learn more ...